Search results for " enzyme"

showing 10 items of 791 documents

Blue Biotechnology and Cultural Heritage: case studies

2015

In order to promote innovative methodologies for conservation and restoration of historic-artistic manufacts, the efforts are focalized on the development of “sustainable” applications as alternatives to traditional restoration procedures, which can sometimes be detrimental for the artworks, humans and environment [1]. The role of Biotechnology in this field showed very useful applications for diagnosis of bio-deterioration of cultural assets, by an integrated methodology based on molecular and microbiological skills, and in bio-cleaning / bio-removing of organic/inorganic layers from artwork surfaces by enzymes or viable bacteria cells [2, 3]. In this work, bioactive molecules isolated fro…

Biocleaning; Enzymes; Cultural HeritageEnzymeBiocleaningCultural Heritage
researchProduct

Enzymatic biodiesel: Challenges and opportunities

2014

The chemical-catalyzed transesterification of vegetable oils to biodiesel has been industrially adopted due to its high conversion rates and low production time. However, this process suffers from several inherent drawbacks related to energy-intensive and environmentally unfriendly processing steps such as catalyst and product recovery, and waste water treatment. This has led to the development of the immobilized enzyme catalyzed process for biodiesel production which is characterized by certain environmental and economical advantages over the conventional chemical method. These include room-temperature reaction conditions, elimination of treatment costs associated with recovery of chemical…

BiodieselImmobilized enzymeChemistryMechanical EngineeringContext (language use)Building and ConstructionTransesterificationManagement Monitoring Policy and LawPulp and paper industrychemistry.chemical_compoundGeneral EnergyBiofuelBiodiesel productionGlycerolOrganic chemistryRenewable resourceApplied Energy
researchProduct

Phosphorylation of cytochromes P450: First discovery of a posttranslational modification of a drug-metabolizing enzyme

2005

Cytochromes P450 (CYP) are important components of xenobiotic-metabolizing monooxygenases (CYP-dependent monooxygenases). Their regulation by induction, most commonly by transcriptional activation, mediated by xenobiotics, normally substrates of the corresponding CYP, is well known and has been widely studied. Our team has discovered an additional important regulation of xenobiotic-metabolizing CYPs pertaining to posttranslational modification by phosphorylation. Individual CYPs are phosphorylated by different protein kinases, leading to CYP isoenzyme-selective changes in the metabolism of individual substrates and consequent drastic changes in the control of genotoxic metabolites. Best stu…

Biophysicsurologic and male genital diseasesBiochemistryCytochrome P-450 Enzyme SystemAnimalsHumansheterocyclic compoundsPhosphorylationEnzyme inducerProtein kinase AMolecular BiologyTranscription factorRegulation of gene expressionbiologyKinaseorganic chemicalsCell Biologyrespiratory systemMonooxygenaseenzymes and coenzymes (carbohydrates)LiverBiochemistrybiology.proteinPhosphorylationProtein Processing Post-TranslationalNuclear localization sequenceMutagensBiochemical and Biophysical Research Communications
researchProduct

Bis(hydroxyphenyl)methane-bisphenol F-metabolism by the HepG2 human hepatoma cell line and cryopreserved human hepatocytes

2011

author cannot archive publisher's version/PDF; International audience; Bisphenol F (BPF) is present in the environment and as a contaminant of food. Humans may, therefore, be exposed to BPF, and an assessment of this risk is required. BPF has been shown to have genotoxic and endocrine-disruptor properties in a human hepatoma cell line (HepG2), which is a model system for studies of xenobiotic toxicity. In this study, we investigated the ability of HepG2 cells to biotransform BPF, because metabolism may affect the observed effects of BPF, and we compared this metabolic capacity with that of human hepatocytes. Cells were incubated for 24 hours with [(3)H]-BPF. The culture medium was then conc…

Bisphenol FHealth Toxicology and MutagenesisestrogenicityCell Culture Techniques010501 environmental sciencesToxicology01 natural sciencesMass SpectrometryCryopreservationchemistry.chemical_compoundenzyme level[SDV.IDA]Life Sciences [q-bio]/Food engineeringperformance liquid chromatographyratLuciferasesinductionChromatography High Pressure Liquidendocrine disruptor0303 health sciencesfood and environmental contaminantMolecular StructureHep G2 CellsGeneral MedicineBiochemistryHepg2 cellsin vitro modeldispositionToxicityEnvironmental Pollutantsliver enzymebiotransformationGlucuronidePlasmidsBiologyTransfectionliver03 medical and health sciencesHumans[SPI.GPROC]Engineering Sciences [physics]/Chemical and Process EngineeringBenzhydryl Compounds030304 developmental biology0105 earth and related environmental sciencesCryopreservationPharmacologyChemical Health and Safetyactivitybisphenol aEstrogen Receptor alphaPublic Health Environmental and Occupational HealthMetabolismbeta-GalactosidaseHepatoma cell linechemistryHepatocytesXenobiotic
researchProduct

Profiling the physiological and molecular response to sulfonamidic drag in Procambarus clarkii

2014

Sulfamethoxazole (SMZ) is one of the most widely employed sulfonamides. Because of the widespread use of SMZ, a considerable amount is indeed expected to be introduced into the environment. The cytotoxicity of SMZ relies mainly on arylhydroxylamine metabolites (S-NOH) of SMZ and it is associated with the production of reactive oxygen species (ROS). There is limited information about the toxic potential of SMZ at the cellular and molecular levels, especially in aquatic and/or non-target organisms. In the present study, the red swamp crayfish (Procambarus clarkii), being tolerant to extreme environmental conditions and resistant to disease, was used as a model organism to profile the molecula…

Blood GlucoseGillsHemocytesAntioxidantSulfamethoxazolePhysiologyHealth Toxicology and Mutagenesismedicine.medical_treatmentHepatopancreasHaemolymphatic parametersAquacultureAstacoideaToxicologyBiochemistryArthropod ProteinsAnti-Infective AgentsRed swamp crayfishStress PhysiologicalGene expressionmedicineAnimalsMetallothioneinHSP70 Heat-Shock ProteinsTissue DistributionAntiossidanti enzymesharmony patio parameters proinflammatory genes red swap crac fish sulfametoxazoleProcambarus clarkiichemistry.chemical_classificationReactive oxygen speciesbiologyGene Expression Regulation DevelopmentalProinflammatory genesCell BiologyGeneral Medicinebiology.organism_classificationBlood Cell CountHsp70FerritinBiochemistrychemistryMolecular ResponseFerritinsbiology.proteinMetallothioneinAntioxidant enzymesOxidoreductasesBiomarkersWater Pollutants Chemical
researchProduct

POSTPRANDIAL HYPERGLYCEMIA IS A DETERMINANT OF PLATELET ACTIVATION IN EARLY 2 DIABETES MELLITUS

2010

BACKGROUND: Chronic hyperglycemia is a major contributor to in vivo platelet activation in diabetes mellitus. OBJECTIVES: To evaluate the effects of acarbose, an alpha-glucosidase inhibitor, on platelet activation and its determinants in newly diagnosed type 2 diabetic patients. METHODS: Forty-eight subjects (26 males, aged 61 +/- 8 years) with early type 2 diabetes (baseline hemoglobin A(1c) < or = 7% and no previous hypoglycemic treatment) were randomly assigned to acarbose up to 100 mg three times a day or placebo, and evaluated every 4 weeks for 20 weeks. The main outcome measures were urinary 11-dehydro-thromboxane (TX)B(2) (marker of in vivo platelet activation) and 8-iso-prostaglandi…

Blood GlucoseMaleTime FactorsSettore MED/09 - Medicina InternaDinoprostpostprandial hyperglycemia; platelet activationMedicineEnzyme InhibitorsSettore MED/49 - Scienze Tecniche Dietetiche Applicatepostprandial hyperglycemiaAcarboseplateletHemoglobin AHematologyMiddle AgedPostprandial PeriodP-SelectinPostprandialTreatment OutcomeC-Reactive ProteinItalyFemaleBiological MarkersAcarboseType 2medicine.drugacarbose platelet activation postprandial hyperglycemia type 2 diabetes mellitusmedicine.medical_specialtySettore BIO/14 - FARMACOLOGIAUrinary systemCD40 LigandGlycosylatedArginineExcretionBlood Glucose; Time Factors; Lipid Peroxidation; Middle Aged; Hemoglobin A Glycosylated; Postprandial Period; Diabetes Mellitus Type 2; Enzyme Inhibitors; Hypoglycemic Agents; P-Selectin; Platelet Activation; Aged; CD40 Ligand; Treatment Outcome; Male; Female; Thromboxane B2; Dinoprost; Italy; Arginine; Acarbose; Double-Blind Method; Humans; Biological Markers; Hyperglycemia; alpha-Glucosidases; C-Reactive ProteinDouble-Blind MethodInternal medicineDiabetes mellitusDiabetes MellitusHypoglycemic AgentsHumansGlycoside Hydrolase InhibitorsPlatelet activationGlycemicAgedGlycated Hemoglobinbusiness.industryType 2 Diabetes Mellitusalpha-Glucosidasesmedicine.diseasePlatelet ActivationThromboxane B2EndocrinologyDiabetes Mellitus Type 2HyperglycemiaLipid PeroxidationbusinessBiomarkers
researchProduct

Cathepsin L in metastatic bone disease: therapeutic implications

2010

AbstractCathepsin L is a lysosomal cysteine proteinase primarily devoted to the metabolic turnover of intracellular proteins. However, accumulating evidence suggests that this endopeptidase might also be implicated in the regulation of other important biological functions, including bone resorption in normal and pathological conditions. These findings support the concept that cathepsin L, in concert with other proteolytic enzymes involved in bone remodeling processes, could contribute to facilitate bone metastasis formation. In support of this hypothesis, recent studies indicate that cathepsin L can foster this process by triggering multiple mechanisms which, in part, differ from those of t…

Bone diseaseClinical BiochemistryBone NeoplasmsBone metastasis; cancer; cathepsin K; cathepsin L; cysteine proteinases; proteinase inhibitorsBiologycathepsin KBiochemistryBone and BonesBone resorptioncathepsin LBone remodelingcysteine proteinaseCathepsin LmedicineCathepsin KAnimalsHumanscancerNeoplasm MetastasisMolecular BiologyCathepsinProteolytic enzymesproteinase inhibitorsBone metastasismedicine.diseaseBone metastasiCancer researchbiology.proteinSettore BIO/14 - Farmacologia
researchProduct

Cylindromatosis (Cyld) gene mutation in T cells promotes the development of an IL-9-dependent allergic phenotype in experimental asthma

2016

Cylindromatosis (CYLD) is a ubiquitously expressed deubiquitinating enzyme which removes activating ubiquitin residues from important signaling molecules of the NF-κB pathway. In CYLDex7/8 transgenic mice, a naturally occurring short isoform (sCYLD) is overexpressed in the absence of full length CYLD, leading to excessive NF-κB activity. Herein, we investigated the impact of the CYLDex7/8 mutation selectively in T cells on the development of experimental allergic airway disease induced by sensitization and challenge with ovalbumin. Compared with their wildtype littermates, mice bearing the T cell-specific mutation (CD4+CYLDex7/8) display stronger eosinophilia and mucus production in the lun…

CD4-Positive T-Lymphocytes0301 basic medicineSkin Neoplasmsmedicine.medical_treatmentT cellImmunologyGene mutationImmunoglobulin Emedicine.disease_causeTh9 cellsDeubiquitinating enzymeMice03 medical and health sciencesNeoplastic Syndromes HereditaryHypersensitivitymedicineAnimalsHumansSensitizationMice KnockoutMutationbiologyTumor Suppressor ProteinsInterleukin-9Cylindromatosis (turban tumor syndrome) geneIL-9AsthmaDeubiquitinating Enzyme CYLDEosinophilsMice Inbred C57BLMucusOvalbumin030104 developmental biologymedicine.anatomical_structureCytokineModels AnimalMutationImmunologybiology.proteinCellular Immunology
researchProduct

DOPAMINE PRO-DRUGS FOR CNS TARGETING: SYNTHESIS, CHARACTERIZATION AND HYDROLYSIS BY BRAIN ENZYMES.

2004

CNSbrain enzymesdopamine pro-drugs
researchProduct

Cytochrome P450 enzymes as human autoantigens

1991

CYP7B1CYP2B6CYP1B1ImmunologyAutoantigensMixed Function OxygenasesCytochrome P-450 Enzyme SystemCytochrome P-450 CYP1A2HumansMedicineHepatitis Chronicchemistry.chemical_classificationbiologybusiness.industryCytochrome P450Cytochrome P450 reductaseCytochrome P-450 CYP2C19EnzymeCytochrome P-450 CYP2D6LiverBiochemistrychemistrybiology.proteinAryl Hydrocarbon HydroxylasesOxidoreductasesbusinessImmunologic Research
researchProduct